Once it’s released, the Cradle-to-Career data system could reshape parents’ and students’ decisions and lead to significant ...

VESPER-2 is a 28-week Phase 2b clinical trial assessing the efficacy and tolerability of different weekly doses of MET-097i with or without titration. The trial enrolled the first participant in March ...

In his first year as governor, Gavin Newsom made the creation of a comprehensive, statewide education data system one of his ...

Received a "Study May Proceed” letter from the FDA to evaluate amezalpat in combination with atezolizumab (TECENTRIQ®) and ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Micah Parsons is expected to ask for a $200 million contract extension that would become a record for a non-quarterback.

Dr. Stefan Glombitza, CEO of Formycon AG, said: “2024 was a year marked by significant milestones for Formycon and substantial progress in our product pipeline ... We believe that Formycon is on track ...

UAE's women-led startup, The Waste Lab, turns organic scraps into nutrient-rich compost, supporting local farms and reducing ...

At The Waste Lab‭, ‬a UAE-based‭, ‬women-owned startup‭, ‬organic waste is collected from homes and commercial kitchens and turned into nutrient-rich compost through a decomposition process‭.‬ ...

Positive azenosertib clinical data demonstrated clinically meaningful results in patients with Cyclin E1+ platinum-resistant ovarian cancer ...

Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement ...

The Ipswich Witches stormed to an impressive 50-40 victory, in the first leg of their Knockout Cup quarter-final tie against the Belle Vue ...